节点文献
早期输尿管癌保肾手术的临床疗效分析(附15例报告)
Clinical analysis of nephron-sparing surgery with early carcinoma of ureter(Report of 15 cases)
【摘要】 目的:探讨早期输尿管癌保留肾脏手术的可行性及疗效。方法:回顾性分析2004年6月~2010年8月15例早期输尿管癌保肾手术患者的临床资料,9例行输尿管节段切除端端吻合术;6例行输尿管末端及膀胱袖口状切除,输尿管膀胱再植术。术后均行膀胱灌注化疗。结果:本组15例患者术后病理均为移行细胞癌。14例获得随访6个月~5年,所有患者同侧输尿管及肾盂均未见复发,2例术后分别于9个月及3年出现膀胱移行细胞癌,术后膀胱癌发生率为14.3%(2/14)。结论:输尿管癌为少见尿路上皮肿瘤,保肾手术有复发的风险。但对早期、低级别输尿管癌,保肾手术效果良好。
【Abstract】 Objective:To evaluate the feasibility and efficacy of partial ureteral resection for primary ureteral carcinoma.Method:From June 2004 to August 2010,15cases of primary ureteral carcinoma with nephron-sparing surgery were retrospectively investigated.This series included 9 cases who had undergone partial ureteral resection,and then restored the continuity of the ureter,and 6 cases who had undergone partial ureteral resection and partial cystectomy,then partial cystectomy received ureterovesical reimplantation.All cases were treated with bladder irrigation of drug after the surgery.Result:The pathological diagnosis of all cases were transitional cell carcinoma.14 cases were followed up for 6 months to 5 years.No case was found transitional cell carcinoma recurrence of ipsilateral ureter or renal pelvis.After 9 months and 3 years of transitional cell carcinoma of the bladder occurred 2 cases in 14 cases,the incidence of bladder cancer after operation is 14.3%(2/14).Conclusion:The carcinoma of ulreter is rare in urothelial tumor.The nephron-sparing surgery has the risk of recurrence,needs to undertake follow-up observation,but to early,low level of primary ureteral tumor surgery effect is good.
【Key words】 carcinoma of ureter; nephron-sparing surgery; clinical efficacy;
- 【文献出处】 临床泌尿外科杂志 ,Journal of Clinical Urology , 编辑部邮箱 ,2013年07期
- 【分类号】R737.13
- 【被引频次】6
- 【下载频次】105